Search

Author/Creator Miteva, D.

3. P778: LONG-TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) FROM THE MEDALIST TRIAL. (23rd June 2022)

Authors:
Fenaux, P.; Santini, V.; Komrokji, R. S.; Zeidan, A.; Garcia-Manero, G.; Buckstein, R.; Miteva, D.; Keeperman, K.; Holot, N.; Zhang, J.; Nadal, J. A.; Rosettani, B.; Yucel, A.; Platzbecker, U.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
673
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P1518: LONG-TERM SAFETY RESULTS OF THE BELIEVE STUDY OF LUSPATERCEPT IN ADULTS WITH ΒETA-THALASSEMIA. (23rd June 2022)

Authors:
Viprakasit, V.; Cappellini, M. D.; Porter, J. B.; Kuo, K. H. M.; Coates, T. D.; Voskaridou, E.; Pinto, V. M.; Tartaglione, I.; Khelif, A.; Lal, A.; Kattamis, A.; Piga, A.; Hermine, O.; Holot, N.; Lersch, F.; Shetty, J. K.; Zhang, J.; Bueno, L.; Giuseppi, A. C.; Miteva, D.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1399
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S270: LONGER-TERM ANALYSIS OF EFFICACY OF LUSPATERCEPT VERSUS PLACEBO IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA ENROLLED IN THE BELIEVE STUDY. (23rd June 2022)

Authors:
Cappellini, M. D.; Taher, A. T.; Porter, J. B.; Kuo, K. H.; Coates, T. D.; Voskaridou, E.; Forni, G. L.; Perrotta, S.; Khelif, A.; Lal, A.; Kattamis, A.; Piga, A.; Hermine, O.; Holot, N.; Lersch, F.; Shetty, J. K.; Vodala, S.; Zhang, J.; Miteva, D.; Viprakasit, V.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗